PubMed

Important considerations in LHRH antagonist therapy for prostate cancer.

Garnick MB.

Oncology (Williston Park). 2009 Jun;23(7):636-7. No abstract available. PMID: 19626833 [PubMed - indexed for MEDLINE]Related articles

Redefining the refined retroperitoneal lymph node dissection in testis cancer: a SWOT analysis of nonrandomized data.

Garnick MB.

J Clin Oncol. 2007 Oct 1;25(28):4337-8. No abstract available. PMID: 17906195 [PubMed - indexed for MEDLINE]Related articles

Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer.

Debruyne F, Bhat G, Garnick MB.

Future Oncol. 2006 Dec;2(6):677-96. Review.PMID: 17155895 [PubMed - indexed for MEDLINE]Related articles

Advanced prostate cancer: an update.

Ziada A, Crawford ED, Schröeder FH, Gleave ME, Miller PD, Garnick MB.

Rev Urol. 2000;2 Suppl 4:S35-9.PMID: 16986039 [PubMed - in process]Related articlesFree article

The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters.

Yannucci J, Manola J, Garnick MB, Bhat G, Bubley GJ.

J Urol. 2006 Aug;176(2):520-5.PMID: 16813881 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics and pharmacodynamics of a novel depot formulation of abarelix, a gonadotropin-releasing hormone (GnRH) antagonist, in healthy men ages 50 to 75.

Wong SL, Lau DT, Baughman SA, Fotheringham N, Menchaca D, Garnick MB.

J Clin Pharmacol. 2004 May;44(5):495-502.PMID: 15102870 [PubMed - indexed for MEDLINE]Related articles

An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists.

Koch M, Steidle C, Brosman S, Centeno A, Gaylis F, Campion M, Garnick MB; Abarelix Study Group.

Urology. 2003 Nov;62(5):877-82.PMID: 14624912 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics and pharmacodynamics of abarelix, a gonadotropin-releasing hormone antagonist, after subcutaneous continuous infusion in patients with prostate cancer.

Wong SL, Lau DT, Baughman SA, Menchaca D, Garnick MB.

Clin Pharmacol Ther. 2003 Apr;73(4):304-11.PMID: 12709720 [PubMed - indexed for MEDLINE]Related articles

A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer.

Trachtenberg J, Gittleman M, Steidle C, Barzell W, Friedel W, Pessis D, Fotheringham N, Campion M, Garnick MB; Abarelix Study Group.

J Urol. 2002 Apr;167(4):1670-4.PMID: 11912385 [PubMed - indexed for MEDLINE]Related articles

A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer.

McLeod D, Zinner N, Tomera K, Gleason D, Fotheringham N, Campion M, Garnick MB; Abarelix Study Group.

Urology. 2001 Nov;58(5):756-61.PMID: 11711355 [PubMed - indexed for MEDLINE]Related articles

The gonadotropin-releasing hormone antagonist abarelix depot versus luteinizing hormone releasing hormone agonists leuprolide or goserelin: initial results of endocrinological and biochemical efficacies in patients with prostate cancer.

Tomera K, Gleason D, Gittelman M, Moseley W, Zinner N, Murdoch M, Menon M, Campion M, Garnick MB.

J Urol. 2001 May;165(5):1585-9.PMID: 11342922 [PubMed - indexed for MEDLINE]Related articles

Overview consensus statement. Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer.

Garnick MB, Fair WR, Bostwick D, Debruyne F, Fourcroy J, Grignon D, Porterfield H, Sufrin G, Thrasher B, Hart C.

Mol Urol. 2000 Fall;4(3):89-92. Review. No abstract available. PMID: 11184767 [PubMed - indexed for MEDLINE]Related articles

Abarelix Depot, a GnRH antagonist, v LHRH superagonists in prostate cancer: differential effects on follicle-stimulating hormone. Abarelix Depot study group.

Garnick MB, Campion M.

Mol Urol. 2000 Fall;4(3):275-7.PMID: 11062384 [PubMed - indexed for MEDLINE]Related articles

Comments on an in vitro model of hormonally refractory prostate cancer.

Joyal JL, Israel DI, Garnick MB.

Cancer J. 2000 Jul-Aug;6(4):213-4. No abstract available. PMID: 11038139 [PubMed - indexed for MEDLINE]Related articles

Pathologic Handling and Reporting of Prostate Tissue Specimens in Patients Receiving Neoadjuvant Hormonal Therapy: Report of the Pathology Committee.

Grignon DJ, Bostwick DG, Civantos F, Garnick MB, Gaudin P, Srigley JR.

Mol Urol. 1999;3(3):193-198.PMID: 10851323 [PubMed - as supplied by publisher]Related articles

Hormonal Therapy in the Management of Prostate Cancer: An Historical Overview.

Garnick MB.

Mol Urol. 1999;3(3):175-182.PMID: 10851321 [PubMed - as supplied by publisher]Related articles

Fourth International Conference on Neoadjuvant Hormonal Therapy of Prostate Cancer: Overview Consensus Statement.

Garnick MB, Fair WR, Goldenberg SL, Gleave M, Grignon D, Fourcroy J, Sufrin G, Porterfield H, Hart C.

Mol Urol. 1999;3(3):171-174. No abstract available. PMID: 10851320 [PubMed - as supplied by publisher]Related articles

Disclosure statements regarding hormonal treatment of prostate cancer.

Garnick MB.

N Engl J Med. 1999 May 27;340(21):1689. No abstract available. PMID: 10348690 [PubMed - indexed for MEDLINE]Related articles

Hormonal treatment of prostate cancer.

Garnick MB.

N Engl J Med. 1999 Mar 11;340(10):812-3. No abstract available. PMID: 10075531 [PubMed - indexed for MEDLINE]Related articles

Combating prostate cancer.

Garnick MB, Fair WR.

Sci Am. 1998 Dec;279(6):74-83. No abstract available. PMID: 9828467 [PubMed - indexed for MEDLINE]Related articles

Genitourinary cancers in older adults.

Morganstern D, Garnick MB.

Clin Geriatr Med. 1998 May;14(2):333-65. Review.PMID: 9536109 [PubMed - indexed for MEDLINE]Related articles

Comparison of perspectives on prostate cancer: analyses of survey data.

Crawford ED, Bennett CL, Stone NN, Knight SJ, DeAntoni E, Sharp L, Garnick MB, Porterfield HA.

Urology. 1997 Sep;50(3):366-72.PMID: 9301699 [PubMed - indexed for MEDLINE]Related articles

Hormonal therapy in the management of prostate cancer: from Huggins to the present.

Garnick MB.

Urology. 1997 Mar;49(3A Suppl):5-15. Review.PMID: 9123737 [PubMed - indexed for MEDLINE]Related articles

First International Conference on Neoadjuvant Hormonal Therapy of Prostate Cancer: overview consensus statement.

Garnick MB, Fair WR.

Urology. 1997 Mar;49(3A Suppl):1-4. Review. No abstract available. PMID: 9123727 [PubMed - indexed for MEDLINE]Related articles

Leydig cell hyperplasia mimicking testicular neoplasm.

Olumi AF, Garnick MB, Renshaw AA, Benson CA, Richie JP.

Urology. 1996 Oct;48(4):647-9.PMID: 8886077 [PubMed - indexed for MEDLINE]Related articles

Neoadjuvant therapy prior to radical prostatectomy: pro.

Fair WR, Garnick MB.

Urology. 1996 Oct;48(4):535-8. No abstract available. PMID: 8886055 [PubMed - indexed for MEDLINE]Related articles

Prostate cancer: emerging concepts. Part II.

Garnick MB, Fair WR.

Ann Intern Med. 1996 Aug 1;125(3):205-12. Review.PMID: 8686979 [PubMed - indexed for MEDLINE]Related articlesFree article

Prostate cancer: emerging concepts. Part I.

Garnick MB, Fair WR.

Ann Intern Med. 1996 Jul 15;125(2):118-25. Review.PMID: 8678366 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.

Tepler I, Elias L, Smith JW 2nd, Hussein M, Rosen G, Chang AY, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA.

Blood. 1996 May 1;87(9):3607-14.PMID: 8611684 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma.

Jakubowski AA, Bajorin DF, Templeton MA, Chapman PB, Cody BV, Thaler H, Tao Y, Filippa DA, Williams L, Sherman ML, Garnick MB, Houghton AN.

Clin Cancer Res. 1996 Feb;2(2):295-302.PMID: 9816172 [PubMed - indexed for MEDLINE]Related articlesFree article

The dilemmas of prostate cancer.

Garnick MB.

Sci Am. 1994 Apr;270(4):72-81. Review. No abstract available. PMID: 8178117 [PubMed - indexed for MEDLINE]Related articles

Prostate cancer: screening, diagnosis, and management.

Garnick MB.

Ann Intern Med. 1993 May 15;118(10):804-18. Review. Erratum in: Ann Intern Med 1994 Apr 15;120(8):698. PMID: 7682387 [PubMed - indexed for MEDLINE]Related articlesFree article

Tumors of the Urinary Tract.

Garnick MB.

West J Med. 1992 May;156(5):556. No abstract available. PMID: 18750877 [PubMed - as supplied by publisher]Related articlesFree article

Long-term followup of 150 patients with testicular cancer treated at a single institution.

Kantoff PW, Kalish LA, McDowell-Bryant P, Canellos GP, Gibbs R, Richie JP, Garnick MB.

J Urol. 1992 Jan;147(1):82-8.PMID: 1370332 [PubMed - indexed for MEDLINE]Related articles

CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded?

Stomper PC, Kalish LA, Garnick MB, Richie JP, Kantoff PW.

Radiology. 1991 Sep;180(3):711-4.PMID: 1651526 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of recombinant human macrophage colony-stimulating factor on plasma cholesterol levels.

Stoudemire JB, Garnick MB.

Blood. 1991 Feb 15;77(4):750-5.PMID: 1993217 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of recombinant human erythropoietin in the management of anemia associated with acquired immunodeficiency syndrome.

Garnick MB, Abels R, Rudnick SA.

Contrib Nephrol. 1991;88:282-92; discussion 293-4. No abstract available. PMID: 2040191 [PubMed - indexed for MEDLINE]Related articles

Clinical applications of recombinant macrophage-colony stimulating factor (rhM-CSF).

VandePol CJ, Garnick MB.

Biotechnol Ther. 1991;2(3-4):231-9. Review.PMID: 1845128 [PubMed - indexed for MEDLINE]Related articles

Initial evaluation and response criteria for patients with superficial bladder cancer. Report of a workshop.

Soloway MS, Murphy WM, Johnson DE, Farrow GM, Paulson DF, Garnick MB.

Br J Urol. 1990 Oct;66(4):380-5. Review. No abstract available. PMID: 2224432 [PubMed - indexed for MEDLINE]Related articles

Leuprolide therapy for prostate cancer. An association with scintigraphic "flare" on bone scan.

Johns WD, Garnick MB, Kaplan WD.

Clin Nucl Med. 1990 Jul;15(7):485-7.PMID: 2116949 [PubMed - indexed for MEDLINE]Related articles

Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.

Munn DH, Garnick MB, Cheung NK.

Blood. 1990 May 15;75(10):2042-8.PMID: 2186820 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates.

Gillio AP, Gasparetto C, Laver J, Abboud M, Bonilla MA, Garnick MB, O'Reilly RJ.

J Clin Invest. 1990 May;85(5):1560-5.PMID: 2332507 [PubMed - indexed for MEDLINE]Related articlesFree article

Biology and management of bladder cancer.

Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP.

N Engl J Med. 1990 Apr 19;322(16):1129-38. Review. No abstract available. PMID: 2181313 [PubMed - indexed for MEDLINE]Related articles

In vivo hematologic effects of recombinant human macrophage colony-stimulating factor.

Ulich TR, del Castillo J, Watson LR, Yin SM, Garnick MB.

Blood. 1990 Feb 15;75(4):846-50.PMID: 2405921 [PubMed - indexed for MEDLINE]Related articlesFree article

Preclinical and clinical evaluation of recombinant human macrophage colony-stimulating factor (rhM-CSF).

Garnick MB, Stoudemire JB.

Int J Cell Cloning. 1990 Jan;8 Suppl 1:356-71; discussion 371-3. Review.PMID: 2182744 [PubMed - indexed for MEDLINE]Related articlesFree article

Psychosocial factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and a control group of healthy men.

Rieker PP, Fitzgerald EM, Kalish LA, Richie JP, Lederman GS, Edbril SD, Garnick MB.

Cancer. 1989 Dec 1;64(11):2399-407.PMID: 2804933 [PubMed - indexed for MEDLINE]Related articles

Clinical promise of new hematopoietic growth factors: M-CSF, IL-3, IL-6.

Garnick MB, O'Reilly RJ.

Hematol Oncol Clin North Am. 1989 Sep;3(3):495-509. Review.PMID: 2698879 [PubMed - indexed for MEDLINE]Related articles

Radiation therapy of seminoma: 17-year experience at the Joint Center for Radiation Therapy.

Lederman GS, Herman TS, Jochelson M, Silver BJ, Chaffey JT, Garnick MB, Richie J, Sheldon TA, Coleman CN.

Radiother Oncol. 1989 Mar;14(3):203-8.PMID: 2710951 [PubMed - indexed for MEDLINE]Related articles

Nodular pneumonitis after cancer chemotherapy.

Talcott JA, Garnick MB, Stomper PC, Godleski JJ, Richie JP.

Ann Intern Med. 1989 Jan 1;110(1):91. No abstract available. PMID: 2908836 [PubMed - indexed for MEDLINE]Related articles

Testicular cancer.

Garnick MB.

Semin Surg Oncol. 1989;5(4):221-6. Review.PMID: 2672228 [PubMed - indexed for MEDLINE]Related articles